Explore the details of the Ingenus Pharmaceuticals, Llc V. Accord Healthcare, Inc. case under case number 1:23-cv-00377 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00377
Filing Date
Apr 3, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Leiutis Pharmaceuticals LLP -
Ingenus Pharmaceuticals, LLC -
Accord Healthcare, Inc. -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US10993952B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 25, 2025ORDER AFTER PRETRIAL CONFERENCE: IT IS HEREBY ORDERED that a two-day bench trial is set to begin on March 25, 2025. The Proposed Pretrial Order (D.I. 72 ) is ADOPTED with the exception of paragraph 79. The parties shall meet and confer before March 10, 2025, and submit a joint letter as discussed at the pretrial conference. (*See Order for details). Signed by Judge Jennifer L. Hall on 2/25/2025. (ceg) (Entered: 02/25/2025)PACER Document
Feb 26, 2025REDACTED VERSION of 72 Proposed Pretrial Order by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Attachments: # 1 Exhibit 1 - 16)(Taylor, Daniel) (Entered: 02/26/2025)PACER Document
Feb 26, 2025REDACTED VERSION of 72 Proposed Pretrial Order by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Attachments: # 1 Exhibit 1 - 16)(Taylor, Daniel) (Entered: 02/26/2025)Attachment
Mar 10, 2025Joint Letter to The Honorable Jennifer L. Hall from Daniel A. Taylor regarding Trial Time, Deposition Designations, Closing Arguments and Confidential Information. (Taylor, Daniel) (Entered: 03/10/2025)PACER Document
Mar 11, 2025MOTION and [Proposed] Order for a Limited Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Accord Healthcare, Inc. (Delcollo, Renee) Modified on 3/11/2025 (ceg). (Entered: 03/11/2025)PACER Document
Mar 11, 2025SO ORDERED, granting 81 Defendant's Motion and Order for a Limited Exemption from the Standing Order Regarding Personal Electronic Devices for purposes of the pre-trial set-up scheduled for March 24, 2025 and trial scheduled for March 25, 2025. Signed by Judge Jennifer L. Hall on 3/11/2025. (ceg) (Entered: 03/11/2025)PACER Document
Mar 14, 2025ORDER: IT IS HEREBY ORDERED that, pursuant to the parties' letter (D.I. 80 ), each side will have 7.5 hours to try its case in the bench trial scheduled for March 25, 2025. Signed by Judge Jennifer L. Hall on 3/14/2025. (ceg) (Entered: 03/14/2025)PACER Document
Feb 28, 2024ORAL ORDER: The Motions for Claim Construction (D.I. 35, D.I. 36 ) are DENIED. The Court will hear the indefinite defense(s) at the bench trial. The Markman Hearing scheduled for August 13, 2024 is CANCELLED. Ordered by Judge Jennifer L. Hall on 2/28/2024. (ceg) (Entered: 02/28/2024)PACER Document
Jul 17, 2024SO ORDERED, re 52 Stipulation and Order to Extend Time for the Close of Fact Discovery to July 31, 2024. (*Reset Scheduling Order Deadlines: Fact Discovery completed by 7/31/2024). Ordered by Judge Jennifer L. Hall on 7/17/2024. (ceg)PACER Document
Jan 10, 2025Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 1/10/2025. (*Court Reporter Heather Triozzi.) (ceg)PACER Document
Mar 19, 2025MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for the March 24, 2025 Trial Courtroom Setup and the March 25, 2025 Trial - filed by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Attachments: (1) Text of Proposed Order)(Taylor, Daniel)PACER Document
Mar 19, 2025MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for the March 24, 2025 Trial Courtroom Setup and the March 25, 2025 Trial - filed by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Attachments: (1) Text of Proposed Order)(Taylor, Daniel)Attachment
Mar 19, 2025ORDER granting [84] Plaintiffs' Motion for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for purposes of the March 24, 2025 Trial Courtroom Setup and the March 25, 2025 Trial. Signed by Judge Jennifer L. Hall on 3/19/2025. (ceg)PACER Document
Mar 21, 2025STIPULATION and [PROPOSED] Order to CONTINUE Trial and to STAY the Action by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Taylor, Daniel)PACER Document
Mar 24, 2025SO ORDERED, re [86] Stipulation and Order to Continue Trial and to Stay the Action. The parties shall submit a Joint Status Report no later than June 20, 2025. (Case stayed). Signed by Judge Jennifer L. Hall on 3/24/2025. (ceg)PACER Document
Mar 28, 2025STIPULATION of Dismissal by Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP. (Taylor, Daniel)PACER Document
Apr 1, 2025SO ORDERED, re [88] Stipulation and Order of Dismissal without prejudice. (Civil Case Terminated). Signed by Judge Jennifer L. Hall on 4/1/2025. (ceg)PACER Document
Apr 1, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,993,952. (Attachments: (1) Stipulation of Dismissal)(ceg)PACER Document
Apr 1, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,993,952. (Attachments: (1) Stipulation of Dismissal)(ceg)Attachment
Apr 2, 2025Official Transcript of Pretrial Videoconference held on 02/25/25 before Judge Jennifer L. Hall. Court Reporter Heather M. Triozzi,Email: [email protected]. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/23/2025. Redacted Transcript Deadline set for 5/5/2025. Release of Transcript Restriction set for 7/1/2025. (Triozzi, Heather)PACER Document